ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Cigarette Smoking in Living Kidney Donors and Graft Survival

    S. Waits, K. Sheetz, M. Terjimanian, K. Barnhart, M. Englesbe

    General Surgery, Division of Transplant Surgery, University of Michigan, Ann Arbor, MI

    Background: The deleterious effects of cigarette smoking contribute to a number of significant health-related problems but the effect of donor smoking history on kidney graft…
  • 2013 American Transplant Congress

    Risk of Transmission of Cancer from Solid Organ Donors in the U.S

    E. Engels

    National Cancer Institute, Rockville, MD

    Background: Transmission (TX) of cancer is a rare but life-threatening complication of transplantation. Most cancers preclude donation, but some may be missed if an accurate…
  • 2013 American Transplant Congress

    Efficacy and Safety of Calcineurin Inhibitor Withdrawal in Living Donor Kidney Transplantation with Older Donors

    G. Chen, L. Chen, J. Qiu, C. Wang, J. Fei, S. Deng, J. Li, G. Huang, Q. Fu

    Organ Transplant Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

    Background: Living donor kidney transplantation recipients with older donors often have lower GFR than whom with young donors after transplantation. Calcineurin inhibitor (CNI) may cause…
  • 2013 American Transplant Congress

    Long-Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys

    S. Florman, J. Pestana, M. Rial, L. Rostaing, J. Grinyo, Y. van Renterghem, F. Muhlbacher, L. Pupim, B. Charpentier

    Mount Sinai Medical Center, NY, NY; Hospital do Rim e Hipertensão, Sao Paolo, Brazil; Instituto de Nefrologia, Buenos Aires, Argentina; University Hospital, Toulouse, France; University Hospital Bellvitge, Barcelona, Spain; University Hospital Leuven, Leuven, Belgium; Vienna Transplantation Center, Vienna, Austria; Bristol-Myers Squibb, Princeton, NJ; Bicêtre Hospital, Kremlin Bicêtre, France

    Background: Kidney transplant recipients treated with belatacept-based immunosuppression in the BENEFIT-EXT study had comparable patient and graft survival and better renal function vs a cyclosporine-based…
  • 2013 American Transplant Congress

    Triple Non-Steroidal Maintenance Therapy in a Cohort of Kidney Transplanted Children

    R. Vilalta, E. Lara, A. Madrid, M. Muñoz, S. Chocron, G. Ariceta

    Paediatric Nephrology Department, Hospital Vall d'Hebron, Barcelona, Spain

    BACKGROUND:Calcineuric inhibitors (CNI) avoidance or dose reduction has been proposed in pediatric kidney transplant (KTx) recipients with nephrotoxicity or neurologic side effects. Combination of CNI,…
  • 2013 American Transplant Congress

    Medication Non-Adherence after Kidney Transplantation: A Qualitative Study Using Depth Interviews of Adherent and Non-Adherent Patients

    F. Weng, E. Clark, S. Chandwani, K. Hahn, K. Demissie, L. Clemow

    Renal & Pancreas Transplant Division, Saint Barnabas Medical Center, Livingston, NJ; University of Medicine & Dentistry of New Jersey, Piscataway, NJ

    Background: Non-adherence to immunosuppressive medications is an important cause of allograft loss after kidney transplant. To examine factors influencing medication adherence in adult kidney transplant…
  • 2013 American Transplant Congress

    Molecular Markers To Distinguish Modes of Renal Graft Rejection

    M. Mikula, K. Livingston, O. Zhukov, F. Hantash, K. Zhang, J. Rion, P. Putheti, C. Snopkowski, A. Buller-Burckle, J. Popov, W. Sun, B. Crossley, M. Hernandez-Fuentes, S. Sacks, M. Suthanthiran, T. Strom, C. Strom, S. Naides

    Quest Diagnostics Nichols Institute, SJC, CA; Beth Israel Deaconess Medical Center, Boston, MA; NY Presbyterian Hospital-Weill Cornell Medical Center, NYC, NY; King's College, London, England, United Kingdom

    Renal transplant recipients may suffer serious consequences from graft rejection. We sought to develop an accurate, noninvasive test that can detect and distinguish acute cellular…
  • 2013 American Transplant Congress

    Role of Commensal Microbiota in Skin Allograft Rejection

    C. Bartman, Y. Wang, P. Zhou, L. Molinero, M. Alegre

    Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL

    A multitude of recent studies have demonstrated that the intestinal microbiota influences systemic autoimmunity and immune responses to infection. Organs associated with commensal bacteria, including…
  • 2013 American Transplant Congress

    Time to Presentation of Donor Derived Infection

    D. Kaul, E. Dominguez, N. Siparsky, C. Wolfe, S. Taranto, S. Covington, E. Blumberg, M. Green

    OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC), Richmond, VA; United Network for Organ Sharing, Richmond, VA

    Background: Differentiating donor-derived infection (DDI) from other causes of illness after solid organ transplantation (SOT) can be challenging. Early recognition of potential DDI allows treatment/prevention…
  • 2013 American Transplant Congress

    CD40-Dependent Help by CD4 T Cells Is Required for CD8 T Cell Recovery after Antithymocyte Globulin Lymphoablation

    K. Ayasoufi, X. Wang, H. Yu, A. Valujskikh

    The Cleveland Clinic, Cleveland

    Antithymocyte globulin (ATG) is a lymphoablative agent used in transplant patients. However, ATG treated recipients eventually reconstitute their T cell repertoire, develop anti-donor immune responses…
  • « Previous Page
  • 1
  • …
  • 1639
  • 1640
  • 1641
  • 1642
  • 1643
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences